Full text is available at the source.
Abstract
Ponatinib can cause serious cardiovascular toxicity, which may be linked to mitochondrial dysfunction.
- Mitochondrial dysfunction is associated with ponatinib's cardiovascular toxicity.
- The mechanism by which ponatinib affects mitochondrial quality control is not well understood.
- The PGAM5/VDAC1 axis may play a role in ponatinib-induced cardiac injury.
- Ponatinib exposure could disrupt both mitophagy and the mitochondrial unfolded protein response.
Simplified